[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Haermonics BV\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":4},"100556136","usability-of-pericardial-flushing-with-the-haermonics-pure-system-after-cardiac-surgery-100556136",false,"NCT06521164","Usability of Pericardial Flushing with the Haermonics Pure System After Cardiac Surgery","USEPURE","Inclusion Criteria:\n\n1. Adult patients (≥18yrs and weight ≥40kg) undergoing cardiothoracic surgery (CABG and\u002For valve surgery, elective aortic surgery, Bentall procedure, ascending aorto\u002Faortic arch replacement) with the use of cardiopulmonary bypass\n2. Patient has been informed of the nature of the clinical investigation and is willing and able to give written informed consent for investigation participation\n\nExclusion Criteria:\n\n1. Euroscore II \\> 20%\n2. Emergent procedures\n3. Complication during surgery which is life threatening and\u002For requires another surgical intervention\n4. Minimal invasive cardiac surgery procedures (e.g. minithoracotomy and hemisternotomy)\n5. Thoraco-abdominal surgery, or intraoperative injury to the diaphragm leading to an open connection between the thoracic and abdominal cavity\n6. Participation in any study involving an investigational drug or device\n7. Patient is pregnant or nursing\n8. Inability to understand study information","ALL","18 Years",{"count":19,"type":20},65,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to evaluate the usability of the Haermonics Pure system in patients undergoing a cardiac surgery procedure with the use of cardiopulmonary bypass.\n\nAll measurements and interventions are standard of care, except pericardial flushing with the Haermonics Pure system.",[26,27],"Surgical Blood Loss","Surgical Complication",[29,30,31,32,33],"cardiac surgery","therapeutic irrigation","postoperative bleeding","chest tubes","Haermonics Pure System","NOT_YET_RECRUITING","2025-03-11",{"date":37,"type":38},"2025-03-14","ACTUAL",{"date":40,"type":20},"2025-10-01",{"date":42,"type":20},"2026-05",{"name":44,"class":45},"Haermonics BV","INDUSTRY",""]